Publications by authors named "Mojtaba Nofeli"

Claim this Profile
A
Analysis of immunological and biochemical parameters after booster dose vaccination using protein-based and inactivated virus vaccine for safety.
Esmat Malek, Mohammad Hossein Fallah Mehrabadi, Ali Es-Haghi, Mojtaba Nofeli, Ali Rezae Mokaram

Heliyon· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial.
Masoud Solaymani-Dodaran, Saeed Kalantari, Seyed Reza Banihashemi, Ali Es-Haghi, Mojtaba Nofeli

Heliyon· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial.
Saeed Erfanpoor, Seyed Reza Banihashemi, Ladan Mokhbaeralsafa, Saeed Kalantari, Ali Es-Haghi, Mojtaba Nofeli

BMC Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II, Safety and Immunogenicity of RAZI Cov Pars (RCP) SARS Cov-2 Vaccine in Adults Aged 18-70 Years; A Randomized, Double-Blind Clinical Trial.
Arash Mohazzab, Mohammad Hossein Fallah Mehrabadi, Ali Es-Haghi, Saeed Kalantari, Ladan Mokhberalsafa, Mojtaba Nofeli

J Pharm Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial.
Masoud Solaymani Dodaran, Seyed Reza Banihashemi, Ali Es-Haghi, Mohammad Hossein Fallah Mehrabadi, Mojtaba Nofeli

Vaccines (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models.
Seyed Reza Banihashemi, Ali Es-Haghi, Mohammad Hossein Fallah Mehrabadi, Mojtaba Nofeli, Ali Rezaei Mokarram

Front Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Vaccine Delivery Vehicle and Adjuvant Candidate: Bordetella pertussis Inactivated Whole Cells Entrapped in Alginate Microspheres.
Naser Mohammadpour Dounighi, Fereshteh Shahcheraghi, Mehdi Razzaghi-Abyaneh, Mojtaba Nofeli, Hossein Zolfagharian

Curr Pharm Des· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Mediated and Humoral Immune Responses to Bordetella pertussis Inactivated Whole-Cells Encapsulated Alginate Microspheres as a New Vaccine Candidate.
Naser M Dounighi, Fereshteh Shahcheraghi, Mehdi Razzaghi-Abyaneh, Mojtaba Nofeli, Hossein Zolfagharian

Curr Pharm Biotechnol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study on Toxicity Reduction and Potency Induction in Whole-cell Pertussis Vaccine by Developing a New Optimal Inactivation Condition Processed on Bordetella pertussis.
Naser Mohammadpour Dounighi, Mehdi Razzaghi-Abyane, Mojtaba Nofeli, Hossein Zolfagharian, Fereshteh Shahcheraghi

Jundishapur J Microbiol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis